Tumour necrosis factor α (TNFα)-converting enzyme (TACE/ADAM-17, where ADAM stands for a disintegrin and metalloproteinase) releases from the cell surface the extracellular domains of TNF and several other proteins. Previous studies have found that, while purified TACE preferentially cleaves peptides representing the processing sites in TNF and transforming growth factor α, the cellular enzyme nonetheless also sheds proteins with divergent cleavage sites very efficiently. More recent work, identifying the cleavage site in the p75 TNF receptor, quantifying the susceptibility of additional peptides to cleavage by TACE and identifying additional protein substrates, underlines the complexity of TACE-substrate interactions. In addition to substrate specificity, the mechanism underlying the increased rate of shedding caused by agents that activate cells remains poorly understood. Recent work in this area, utilizing a peptide substrate as a probe for cellular TACE activity, indicates that the intrinsic activity of the enzyme is somehow increased.
Skip Nav Destination
Article navigation
September 2003
Issue Editors
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
Conference Article|
September 01 2003
Substrate specificity and inducibility of TACE (tumour necrosis factor α-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activity
Roy A. Black;
Roy A. Black
1
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
1To whom correspondence should be addressed (e-mail [email protected]).
Search for other works by this author on:
John R. Doedens;
John R. Doedens
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
Search for other works by this author on:
Rajeev Mahimkar;
Rajeev Mahimkar
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
Search for other works by this author on:
Richard Johnson;
Richard Johnson
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
Search for other works by this author on:
Lin Guo;
Lin Guo
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
Search for other works by this author on:
Alison Wallace;
Alison Wallace
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
Search for other works by this author on:
Duke Virca;
Duke Virca
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
Search for other works by this author on:
June Eisenman;
June Eisenman
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
Search for other works by this author on:
Jennifer Slack;
Jennifer Slack
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
Search for other works by this author on:
Beverly Castner;
Beverly Castner
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
Search for other works by this author on:
Susan W. Sunnarborg;
Susan W. Sunnarborg
†Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, NC 27599, U.S.A.
Search for other works by this author on:
David C. Lee;
David C. Lee
†Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, NC 27599, U.S.A.
Search for other works by this author on:
Rebecca Cowling;
Rebecca Cowling
‡Department of Biological Chemistry, Wyeth-Ayerst Research, Pearl River, NY 10965, U.S.A.
Search for other works by this author on:
Guixian Jin;
Guixian Jin
‡Department of Biological Chemistry, Wyeth-Ayerst Research, Pearl River, NY 10965, U.S.A.
Search for other works by this author on:
Keith Charrier;
Keith Charrier
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
Search for other works by this author on:
Jacques J. Peschon;
Jacques J. Peschon
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
Search for other works by this author on:
Ray Paxton
Ray Paxton
*Amgen Inc., 51 University Street, Seattle, WA 98101, U.S.A.
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1744-1439
Print ISSN: 0067-8694
© 2003 The Biochemical Society
2003
Biochem Soc Symp (2003) 70: 39–52.
Citation
Jeremy Saklatvala, Hideaki Nagase, Guy Salvesen, Roy A. Black, John R. Doedens, Rajeev Mahimkar, Richard Johnson, Lin Guo, Alison Wallace, Duke Virca, June Eisenman, Jennifer Slack, Beverly Castner, Susan W. Sunnarborg, David C. Lee, Rebecca Cowling, Guixian Jin, Keith Charrier, Jacques J. Peschon, Ray Paxton; Substrate specificity and inducibility of TACE (tumour necrosis factor α-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activity. Biochem Soc Symp 1 September 2003; 70 39–52. doi: https://doi.org/10.1042/bss0700039
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Related Articles
Shedding of membrane proteins by ADAM family proteases
Essays Biochem (October,2002)
Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10
Biochem J (October,2009)
Intracellular maturation and localization of the tumour necrosis factor α convertase (TACE)
Biochem J (March,2000)
MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17
Biochem J (August,2004)